Pharma-Bio Serv, Inc.
Close on Oct 19, 2026
- Market cap
- $11.00M
- P/E (TTM)
- 48.0
- Dividend yield
- –
Earnings
Next report expected Jan 28, 2027, during market hours (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q3 FY2026 Ended Jul 31, 2026 | Sep 14, 2026 | During market hours | $2.30M | – | – |
| Q2 FY2026 Ended Apr 30, 2026 | Jun 15, 2026 | During market hours | $2.70M | – | – |
| Q1 FY2026 Ended Jan 31, 2026 | Mar 17, 2026 | During market hours | $2.30M | – | – |
| Q4 FY2025 Ended Oct 31, 2025 | Jan 29, 2026 | During market hours | – | – | – |
| Q3 FY2025 Ended Jul 31, 2025 | Sep 15, 2025 | During market hours | $2.00M | – | – |
| Q2 FY2025 Ended Apr 30, 2025 | Jun 16, 2025 | During market hours | $2.40M | – | – |
| Q1 FY2025 Ended Jan 31, 2025 | Mar 17, 2025 | During market hours | $2.50M | – | – |
| Q4 FY2024 Ended Oct 31, 2024 | Jan 29, 2025 | During market hours | – | – | – |
| Q3 FY2024 Ended Jul 31, 2024 | Sep 16, 2024 | During market hours | – | – | – |
| Q2 FY2024 Ended Apr 30, 2024 | Jun 14, 2024 | During market hours | – | – | – |
| Q1 FY2024 Ended Jan 31, 2024 | Mar 18, 2024 | During market hours | – | – | – |
Press releases
Announcements Pharma-Bio Serv filed with the SEC
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2026
Results of operations · EX-99.1 to Form 8-K
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2026
Results of operations · EX-99.1 to Form 8-K
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2026
Results of operations · EX-99.1 to Form 8-K
Pharma-Bio Serv Announces Full Year Results and Special Dividend
Results of operations · EX-99.1 to Form 8-K
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2025
Results of operations · EX-99.1 to Form 8-K
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2025
Results of operations · EX-99.1 to Form 8-K
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2025
Results of operations · EX-99.1 to Form 8-K
Pharma-Bio Serv Announces Full Year Results
Results of operations · EX-99.1 to Form 8-K
Pharma-Bio Serv Announces Special Dividend
Other events · EX-99.1 to Form 8-K
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2024
Results of operations · EX-99.1 to Form 8-K
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2024
Results of operations · EX-99.1 to Form 8-K
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2024
Results of operations · EX-99.1 to Form 8-K
Pharma-Bio Serv Announces Full Year Results
Results of operations · EX-99.1 to Form 8-K
Pharma-Bio Serv Announces Special Dividend
Other events · EX-99.1 to Form 8-K
Pharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2023
Results of operations · EX-99.1 to Form 8-K
Pharma-Bio Serv Announces Results for the Three and Six Months Ended April 30, 2023
Results of operations · EX-99.1 to Form 8-K
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2023
Results of operations · EX-99.1 to Form 8-K
Pharma-Bio Serv Announces Special Dividend
Other events · EX-99.1 to Form 8-K
Pharma-Bio Serv Retains Investment Banking Firm
Other events · EX-99.1 to Form 8-K
Pharma-Bio Serv Announces Full Year Results
Results of operations · EX-99.1 to Form 8-K
Pharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2022
Results of operations · EX-99.1 to Form 8-K
Pharma-Bio Serv Announces Results for the Three and Six Months Ended April 30, 2022
Results of operations · EX-99.1 to Form 8-K
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2022
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED FEBRUARY 11, 2022.
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE DATED NOVEMBER 15, 2021
Other events · EX-99.1 to Form 8-K